David Preiss

10PUBLICATIONS

52CO-AUTHORS

Vision scienceOptical technologyMajor global burdens of diseaseBehavioural epidemiologyPharmacogenomics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|May 12, 2026

Fenofibrate and progression of retinopathy in adults with diabetes: the randomised placebo-controlled LENS trial.

|Jul 03, 2025

Cost-effectiveness of fenofibrate versus standard care for reducing the progression of diabetic retinopathy: An economic evaluation based on data from the LENS trial.

Graham Scotland, Mekazin Tsehaye, Caroline Styles

|Apr 03, 2025

Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.

Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin

|Oct 25, 2024

Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.

William G Herrington, Natalie Staplin, Nikita Agrawal

|Jul 01, 2024

Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial.

Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin

|Dec 12, 2023

Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD.

Kaitlin J Mayne, Natalie Staplin, David F Keane

Pageof 2

Frequent Collaborators

Jonathan Emberson

Katherine R Tuttle

Parminder K Judge

Richard Haynes

Christoph Wanner

Natalie Staplin

Emily Sammons

Xavier Rossello

Kaitlin J Mayne

Inna Thalmann

Frequent Collaborators

Jonathan Emberson

Katherine R Tuttle

Parminder K Judge

Richard Haynes